Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by OLIVARESJaime Rodríguez of Olivares explains the implications of the revocation by the Mexican Federal Court of Administrative Affairs of the criteria commonly used to allow complainants to credit their legal standing on trademark non-use cancellation proceedings -
Sponsored by FB RiceStefania Sassnink and Paul Whenman of FB Rice provide a guide to when third parties can be held responsible for patent infringement on the basis of supplying a product
-
Sponsored by LexOrbisAn overhaul of the Indian patent application system has cut the time taken to reach a decision. Joginder Singh and Piyush Sharma of LexOrbis examine the new process and the implications
-
Sponsored by LexOrbisRitika Agarwal and Sanjana J Kamat of LexOrbis summarise a ruling by the High Court of Delhi regarding proof of use and explain what it means with regard to the use of internet extracts in providing evidence
-
Sponsored by Maiwald Intellectual PropertySusanna Heurung of Maiwald examines a decision by the European Court of Justice concerning the ending of a period of ‘acquiescence’ in a trademark case and what it means for potential plaintiffs
-
Sponsored by AJ ParkAJ Park reports that the introduction of an Artist Resale Royalty Scheme in New Zealand has been well received and is expected to enhance the country’s creative profile
